Urinary Catheters Market Size, Share, Growth, and Industry Analysis, By Type (Intermittent Catheters, Foley/ Indwelling Catheters, External Catheters), By Application (Hospitals, Homecare, Others), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

URINARY CATHETERS MARKET OVERVIEW

The global Urinary Catheters Market size estimated at USD 2.22 billion in 2026 and is projected to reach USD 4.6 billion by 2035, growing at a CAGR of 8.45% from 2026 to 2035.

The urinary catheters market is witnessing steady expansion due to the increasing prevalence of urinary incontinence, benign prostatic hyperplasia, spinal cord injuries, and postoperative urinary retention. More than 423 million people worldwide experience urinary incontinence, while over 200 million individuals are estimated to suffer from bladder control disorders. Urinary catheter utilization in acute care facilities exceeds 25% of hospitalized patients globally. Foley catheters remain the most commonly used products, accounting for approximately 52% of total catheter utilization. Antimicrobial-coated catheter adoption has reached 31% of newly procured hospital catheter inventories. Single-use intermittent catheters represent nearly 38% of total annual urinary catheter consumption worldwide.

The United States represents one of the largest urinary catheter consumption markets due to its substantial elderly population and high hospitalization rates. More than 58 million Americans are aged 65 years and above, creating significant demand for urinary management products. Approximately 12% of hospitalized patients in the U.S. receive urinary catheterization during treatment. Catheter-associated urinary tract infections account for nearly 75% of hospital-acquired urinary infections. More than 30 million urinary catheter units are utilized annually across hospitals, nursing facilities, and homecare settings. Home-based urinary catheter adoption has increased significantly, with over 4 million patients relying on intermittent or indwelling catheterization for long-term bladder management.

KEY FINDINGS

LATEST TRENDS

The urinary catheters market is experiencing substantial transformation driven by technological innovation and patient-centric product development. Hydrophilic-coated catheters have achieved approximately 42% adoption among intermittent catheter users due to reduced friction and improved comfort. Silicone-based urinary catheters account for nearly 47% of newly procured hospital inventories because of enhanced biocompatibility and reduced latex sensitivity risks.

Antimicrobial-coated urinary catheters continue gaining traction, representing 31% of advanced catheter purchases in developed healthcare systems. Silver-alloy coatings have demonstrated reductions in bacterial colonization exceeding 35% in clinical evaluations. Healthcare facilities increasingly prioritize infection prevention programs, with catheter management protocols implemented in more than 68% of tertiary hospitals.

MARKET DYNAMICS

Driver

Rising prevalence of urinary incontinence and urological disorders.

The growing burden of urinary disorders remains the primary growth driver for the urinary catheters market. More than 423 million individuals worldwide experience urinary incontinence, while benign prostatic hyperplasia affects over 210 million men. Neurogenic bladder disorders impact approximately 80 million people globally. Hospital admissions involving urinary retention continue increasing, with catheterization required in nearly 15% of surgical procedures. Aging demographics further contribute to demand, as urinary dysfunction prevalence exceeds 30% among individuals older than 65 years.

Restraint

High incidence of catheter-associated urinary tract infections.

Catheter-associated urinary tract infections remain a significant restraint for market expansion. Approximately 75% of hospital-acquired urinary tract infections are linked to catheter use. Infection risk increases by 5% per catheterization day, creating substantial concerns among healthcare providers. Nearly 25% of patients requiring prolonged catheterization experience complications such as infections, urethral trauma, or blockages. Hospitals continue implementing catheter reduction initiatives, with some facilities achieving 20% declines in unnecessary catheter placements.

Expansion of homecare and self-catheterization practices

Opportunity

Homecare healthcare delivery presents significant opportunities within the urinary catheters market. Approximately 35% of catheter users manage bladder conditions outside institutional healthcare settings. Self-catheterization adoption has increased by nearly 28% among patients with spinal cord injuries and neurogenic bladder disorders.

Hydrophilic intermittent catheters demonstrate user satisfaction rates above 80%, encouraging broader utilization. Telemedicine consultations associated with chronic urinary care increased by 22%, facilitating improved patient monitoring.

Pricing pressures and stringent regulatory requirements

Challenge

The urinary catheters market faces challenges related to manufacturing standards and regulatory compliance. More than 60% of catheter manufacturers allocate significant resources toward quality assurance and certification activities. Product recalls linked to packaging defects, sterility concerns, or material inconsistencies affect approximately 3% of annual medical device notifications.

Healthcare providers increasingly demand evidence-based performance data, requiring extensive clinical validation. Procurement organizations emphasize cost containment, leading to competitive pricing pressures across supplier networks.

•   
•   
  

  Download Free Sample to learn more about this report

    

URINARY CATHETERS MARKET SEGMENTATION

By Type

• Intermittent Catheters: Intermittent catheters account for approximately 38% of the urinary catheters market. These devices are commonly used by patients with spinal cord injuries, neurogenic bladder conditions, and chronic urinary retention. More than 2 million individuals worldwide perform intermittent catheterization regularly. Hydrophilic-coated intermittent catheters comprise nearly 42% of this segment due to improved comfort and reduced friction. Patient compliance rates exceed 80% when advanced lubrication technologies are utilized.

• Foley/Indwelling Catheters: Foley catheters represent approximately 52% of total market share and remain the most widely used urinary catheter type. More than 25% of hospitalized patients require temporary catheterization during treatment. Foley catheters are extensively utilized in surgical recovery, intensive care, and long-term care settings. Silicone Foley catheters account for 47% of hospital procurement volumes due to superior durability. Antimicrobial-coated Foley products represent 31% of advanced catheter purchases.

• External Catheters: External catheters contribute approximately 10% of total urinary catheter demand. These products are primarily designed for male urinary incontinence management and offer non-invasive alternatives to indwelling catheterization. Utilization rates have increased by 18% in long-term care facilities focused on infection reduction initiatives. Nearly 70% of external catheter users are aged above 60 years. Product innovations involving skin-friendly adhesives and breathable materials have improved wear times by approximately 25%.

By Application

• Hospitals: Hospitals account for approximately 61% of urinary catheter demand globally. More than 230 million major surgical procedures are performed annually worldwide, creating substantial catheter utilization requirements. Intensive care units report catheterization rates exceeding 70% among critically ill patients. Catheter-associated infection prevention programs are implemented in nearly 68% of tertiary hospitals. Foley catheters dominate hospital consumption, representing more than 75% of institutional procurement volumes.

• Homecare: Homecare represents approximately 27% of the urinary catheters market. More than 4 million individuals rely on home-based catheter management programs globally. Intermittent catheters account for nearly 60% of homecare catheter utilization due to patient convenience. Telehealth support for chronic urinary management has increased by 22%, improving adherence and monitoring. Elderly patients represent over 55% of homecare catheter users. Portable and discreet catheter designs continue gaining popularity, particularly among active adults.

• Others: Other applications account for approximately 12% of the urinary catheters market and include rehabilitation centers, outpatient clinics, nursing homes, and specialty care facilities. Long-term care institutions report catheter utilization rates exceeding 20% among residents. Rehabilitation facilities treating spinal cord injuries utilize intermittent catheters in more than 65% of bladder management programs. Outpatient urology clinics perform thousands of catheter-related procedures annually. Infection prevention initiatives and patient comfort considerations increasingly influence product selection across these settings.

•   
•   
  Download Free Sample to learn more about this report

    

URINARY CATHETERS MARKET REGIONAL OUTLOOK

• North America

North America holds approximately 38% of the global urinary catheters market share, making it the leading regional market. The region benefits from a large patient population affected by urinary incontinence, benign prostatic hyperplasia, spinal cord injuries, and postoperative urinary retention. More than 58 million individuals in the United States are aged 65 years and above, representing a substantial target population for urinary catheter products.

Urinary incontinence affects nearly 25 million adults in the region, while bladder dysfunction prevalence exceeds 15% among elderly populations. Hospital catheter utilization remains high, with approximately 12% of admitted patients undergoing catheterization during treatment. Catheter-associated urinary tract infections account for nearly 75% of hospital-acquired urinary infections, encouraging healthcare providers to adopt antimicrobial-coated and silicone-based catheter technologies.

• Europe

Europe accounts for approximately 29% of the global urinary catheters market and remains one of the most mature healthcare regions. The population aged 65 years and above exceeds 150 million across European countries, contributing significantly to urinary catheter demand. Urinary incontinence affects nearly 55 million individuals throughout the region, while lower urinary tract symptoms are reported in approximately 40% of adults older than 60 years.

Hospitals represent the largest end-user segment, accounting for approximately 63% of regional catheter consumption. More than 25 million surgical procedures requiring perioperative urinary management are performed annually across European healthcare systems. Foley catheters continue to dominate utilization patterns, although intermittent catheter adoption has increased due to patient preference and lower infection risks.

• Asia-Pacific

Asia-Pacific accounts for approximately 24% of the urinary catheters market and represents the fastest-expanding regional opportunity due to large patient populations and improving healthcare access. The region contains more than 60% of the global population and over 470 million individuals aged 65 years and above. Rising life expectancy and increasing prevalence of chronic diseases contribute significantly to urinary catheter demand.

China, Japan, India, South Korea, and Australia collectively account for more than 80% of regional catheter consumption. Urinary incontinence prevalence ranges between 12% and 28% among adults in major Asia-Pacific countries. More than 90 million elderly individuals across the region experience some form of bladder dysfunction requiring clinical intervention.

• Middle East & Africa

The Middle East & Africa region accounts for approximately 3% of the global urinary catheters market. Despite its relatively smaller share, healthcare modernization efforts and increasing investments in hospital infrastructure are supporting demand growth. The regional population exceeds 1.5 billion individuals, with a growing proportion of elderly residents requiring urinary management solutions.

Urinary incontinence affects approximately 8% to 15% of adults across major countries within the region. Hospital-based catheterization remains the dominant mode of utilization, accounting for nearly 70% of total demand. More than 10 million surgical procedures are performed annually throughout healthcare facilities in the Middle East and Africa, creating ongoing requirements for urinary catheter products.

LIST OF TOP URINARY CATHETERS COMPANIES

• Teleflex
• Bard Medical
• ConvaTec
• Braun
• Coloplast
• AngioDynamics
• Boston Scientific
• Cook Medical Inc.
• Medtronic
• Hollister
• Terumo
• Amsino
• Pacific Hospital Supply
• Sewoon Medical
• Welllead
• CompactCath
• MTG
• WellSpect HealthCare
• Cure Medical
• Zhanjiang Star Enterprise Co Ltd
• Fuqing Group
• Medsuyun
• Fullcare
• Biociv
• Nantong Anqi Medical Supplies Co Ltd

List Of Top 2 Companies Market Share

• Coloplast – approximately 13% global urinary catheter market share, supported by extensive intermittent catheter portfolios, presence in more than 140 countries, and strong adoption of hydrophilic catheter technologies.
• Teleflex – approximately 11% global urinary catheter market share, driven by broad Foley catheter offerings, distribution across over 120 countries, and significant penetration within hospital-based urinary management procedures.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The urinary catheters market continues attracting investment due to increasing demand for advanced urinary management technologies and expanding elderly populations. More than 423 million people worldwide suffer from urinary incontinence, creating a substantial patient pool for catheter manufacturers. Approximately 31% of healthcare facilities are increasing procurement of antimicrobial-coated catheter products to reduce infection risks and improve patient outcomes.

Investments are increasingly directed toward hydrophilic coating technologies, which account for nearly 42% of intermittent catheter demand. Manufacturers are allocating significant resources toward silicone catheter production, with silicone products representing approximately 47% of new hospital catheter purchases. Production facility expansions have increased manufacturing capacities by approximately 15% among leading suppliers during recent years.

NEW PRODUCT DEVELOPMENT

Product development in the urinary catheters market is increasingly focused on reducing infection rates, improving patient comfort, and enhancing ease of use. Approximately 31% of newly launched catheter products incorporate antimicrobial technologies designed to minimize bacterial colonization and catheter-associated urinary tract infections. Silver-alloy and antibiotic-coated catheter systems have demonstrated bacterial reduction rates exceeding 35% in controlled clinical environments.

Hydrophilic-coated catheters remain a major innovation area, accounting for nearly 42% of advanced intermittent catheter introductions. These products reduce insertion friction by approximately 30% and improve patient satisfaction scores by more than 25%. Manufacturers are also developing pre-lubricated catheter systems that reduce preparation time by nearly 40% compared to conventional devices. Silicone-based catheter innovations continue expanding, with silicone products representing approximately 47% of hospital procurement volumes.

FIVE RECENT DEVELOPMENTS (2023-2025)

• 2025: Coloplast expanded its intermittent catheter portfolio with advanced hydrophilic technology products, improving lubrication performance by approximately 25% and enhancing user convenience for self-catheterization patients.
• 2025: Teleflex increased manufacturing capacity for antimicrobial Foley catheters by approximately 15% to address rising hospital demand for infection-prevention urinary management products.
• 2024: B. Braun introduced silicone-based urinary catheter solutions with improved flexibility characteristics, resulting in approximately 20% greater patient comfort during extended catheterization procedures.
• 2024: ConvaTec expanded distribution of compact intermittent catheter systems across more than 20 additional international markets, strengthening access to portable urinary management devices.
• 2023: WellSpect HealthCare launched updated intermittent catheter designs featuring enhanced ergonomic handling systems, reducing insertion preparation steps by approximately 30% for end users.

URINARY CATHETERS MARKET REPORT COVERAGE

The urinary catheters market report provides comprehensive analysis of product categories, applications, regional performance, competitive positioning, technological advancements, and investment opportunities. The study evaluates three major product types including intermittent catheters, Foley or indwelling catheters, and external catheters. Foley catheters account for approximately 52% of market demand, while intermittent catheters contribute nearly 38% and external catheters represent approximately 10%.

The report examines application segments including hospitals, homecare settings, and other healthcare facilities. Hospitals maintain approximately 61% market share due to high procedure volumes and inpatient catheter utilization. Homecare contributes approximately 27% of demand as self-catheterization adoption continues expanding among patients with chronic urinary disorders. Regional assessment covers North America, Europe, Asia-Pacific, and Middle East & Africa. North America leads with approximately 38% market share, followed by Europe at 29%, Asia-Pacific at 24%, and Middle East & Africa at 3%. The report analyzes healthcare infrastructure development, elderly population trends, urinary disorder prevalence, and adoption rates of advanced catheter technologies.